Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer a Step Closer to Icagen
Yahoo/Zacks.com
Thursday, September 22, 2011 - 5:31pm
tags:
Pfizer, M&A, Icagen
Abbott's Management Is Creating Value
Motley Fool
Thursday, September 22, 2011 - 5:28pm
tags:
Abbott Laboratories
Dendreon Shareholders May Yet Have The Last Laugh
Seeking Alpha
Thursday, September 22, 2011 - 2:26pm
tags:
Dendreon, Provenge, prostate cancer, shareholders, Seattle Genetics
Top High-Dividend Healthcare Stocks
Seeking Alpha
Thursday, September 22, 2011 - 2:20pm
tags:
dividends, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, GSK, JNJ, Eli Lilly, Merck, Novartis, Pfizer, Sanofi
FDA phases out OTC asthma inhalers due to environmental impact
Seattle Post Intelligencer, WA
Thursday, September 22, 2011 - 11:27am
tags:
asthma, OTC, inhaler, FDA
Twitter as biopharma radar
Fierce Pharma Manufacturing
Thursday, September 22, 2011 - 11:23am
tags:
social media, twitter
RXi Licenses Novel, Targeted Cancer Vaccine for Gynecological Cancers
Yahoo/Zacks.com
Thursday, September 22, 2011 - 11:16am
tags:
vaccines, RXi Pharmaceuticals, ovarian cancer, gynecological cancers
Novartis Unveils Upbeat ACZ885 Data
Yahoo/Zacks.com
Thursday, September 22, 2011 - 11:13am
tags:
ACZ885, Novartis, systemic juvenile idiopathic arthritis
Why Bristol-Myers Squibb's Earnings Are Outstanding
Motley Fool
Thursday, September 22, 2011 - 11:12am
tags:
earnings, Bristol-Myers Squibb
Sanofi tackles $3B acne market with UC San Diego pact
Fierce Biotech
Thursday, September 22, 2011 - 9:14am
tags:
vaccines, acne, Sanofi Pasteur
Warner Chilcott Wins Court Ruling Blocking Mylan Copy of Doryx Antibiotic
Bloomberg
Thursday, September 22, 2011 - 9:12am
tags:
Mylan, antibiotics, DORYX, Warner Chilcott, generics
Roche, Mylan Settle Patent Case Over Drug Xeloda
Bloomberg
Thursday, September 22, 2011 - 8:30am
tags:
Mylan, Roche, patents, Xeloda, cancer
Calls for Europe to curb and control off-label use
Pharma Times, UK
Thursday, September 22, 2011 - 8:29am
tags:
off-label, Europe
Spectrum Solidifies Long-Term Potential
Seeking Alpha
Thursday, September 22, 2011 - 8:28am
tags:
Spectrum, Fusilev, colorectal cancer
Human Genome rallies 12% on lupus drug sales
Marketwatch
Wednesday, September 21, 2011 - 11:25pm
tags:
Human Genome Sciences, Benlysta, lupus
Regeneron Soars on Eye-Drug Rival Setback
TheStreet.com
Wednesday, September 21, 2011 - 11:24pm
tags:
Regeneron, Roche, Avastin, wet-AMD, age-related macular degeneration
Insulin Spending Doubles in U.K. on Newer Products, Study Says
Bloomberg
Wednesday, September 21, 2011 - 11:20pm
tags:
United Kingdom, insulin, diabetes
Can Vertex Catch Lightening in a Bottle Again?
Seeking Alpha
Wednesday, September 21, 2011 - 11:15pm
tags:
Vertex, Incivek, hepatitis C, CF, cystic fibrosis, VX-770
J&J Begins to Rebound from Recalls
Barron's
Wednesday, September 21, 2011 - 11:13pm
tags:
recalls, JNJ
Judge orders Teva to honor Baxter deal in hep C litigation
Fierce Pharma
Wednesday, September 21, 2011 - 12:42pm
tags:
Teva Pharmaceuticals, Baxter, hepatitis C

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.